I agree that this site is using cookies. You can find further informations here.
X
Kekre, Natasha
124  results:
Search for persons X
?
1

Economic Evaluations of Chimeric Antigen Receptor T-Cell Th..:

Thavorn, Kednapa ; Thompson, Emily Rose ; Kumar, Srishti...
Value in Health.  , 2024
Link: https://doi.org/10.1016/..
 
?
2

Favorable Outcomes with Low Dose Anti Thymocyte Globulin Ba..:

Chalchal, Hafsah ; Dhir, Vinita ; Abrol, Kalina...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S264 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Safety and efficacy of autologous cell vaccines in solid tu..:

Bastin, Donald J. ; Montroy, Joshua ; Kennedy, Michael A....
Scientific Reports.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
4

Identifying effect modifiers of CAR-T cell therapeutic effi..:

Lalu, Manoj M. ; Kekre, Natasha ; Montroy, Joshua...
Systematic Reviews.  12 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
5

ASTCT Clinical Practice Recommendations for Transplantation..:

Epperla, Narendranath ; Kumar, Ambuj ; Abutalib, Syed A....
Transplantation and Cellular Therapy.  29 (2023)  9 - p. 548-555 , 2023
Link: https://doi.org/10.1016/..
 
?
6

A systematic review and meta-analysis of CD22 CAR T-cells a..:

Fergusson, Nathan J. ; Adeel, Komal ; Kekre, Natasha..
Frontiers in Immunology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
7

The impact of feedback training on prediction of cancer cli..:

Doussau, Adélaïde ; Kane, Patrick ; Peppercorn, Jeffrey...
Clinical Trials.  21 (2023)  2 - p. 143-151 , 2023
Link: https://doi.org/10.1177/..
 
?
8

Optimal Timing of Allogeneic Stem Cell Transplantation for ..:

Cipkar, Christopher ; Kumar, Srishti ; Thavorn, Kednapa.
Transplantation and Cellular Therapy.  28 (2022)  4 - p. 189-194 , 2022
Link: https://doi.org/10.1016/..
 
?
9

Patient-Reported Outcomes (PROs) in Zuma-7, a Phase 3, Rand..:

Elsawy, Mahmoud ; Chavez, Julio C. ; Avivi, Irit...
Transplantation and Cellular Therapy.  28 (2022)  3 - p. S190-S191 , 2022
Link: https://doi.org/10.1016/..
 
?
10

Patient-reported outcomes in ZUMA-7, a phase 3 study of axi..:

Elsawy, Mahmoud ; Chavez, Julio C. ; Avivi, Irit...
Blood.  140 (2022)  21 - p. 2248-2260 , 2022
Link: https://doi.org/10.1182/..
 
?
11

CLIC-01: Manufacture and distribution of non-cryopreserved ..:

Kekre, Natasha ; Hay, Kevin A. ; Webb, John R....
Frontiers in Immunology.  13 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
12

Axicabtagene ciloleucel as first-line therapy in high-risk ..:

Neelapu, Sattva S. ; Dickinson, Michael ; Munoz, Javier...
Nature Medicine.  28 (2022)  4 - p. 735-742 , 2022
Link: https://doi.org/10.1038/..
 
?
13

Acquired hemophilia A following allogeneic stem cell transp..:

Uminski, Kelsey ; Khalife, Roy ; Kekre, Natasha.
Annals of Hematology.  101 (2022)  8 - p. 1861-1863 , 2022
Link: https://doi.org/10.1007/..
 
?
14

Use of CRISPR/Cas9 gene editing to improve chimeric antigen..:

Maganti, Harinad B. ; Kirkham, Aidan M. ; Bailey, Adrian J.M....
Cytotherapy.  24 (2022)  4 - p. 405-412 , 2022
Link: https://doi.org/10.1016/..
 
?
15

Primary Analysis (PA) of Zuma-12: A Phase 2 Study of Axicab..:

Neelapu, Sattva S. ; Dickinson, Michael ; Muñoz, Javier...
Transplantation and Cellular Therapy.  28 (2022)  3 - p. S11-S12 , 2022
Link: https://doi.org/10.1016/..
 
1-15